Showing results (71-80 of 115) with videos related to
Sort By:
Pageof 12
Breast Cancer Research and Treatment|September 20, 2019
Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experienceNicolò Matteo Luca Battisti, Victoria True, Narda Chaabouni, et al.Cancer Chemotherapy and Pharmacology|April 6, 2002
Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patientsChristopher Poole, Jill Gardiner, Chris Twelves, et al.Trials|July 14, 2021
Process evaluation of the Bridging the Age Gap in Breast Cancer decision support intervention cluster randomised trialMaria Burton, Kate J Lifford, Lynda Wyld, et al.European Journal of Cancer (Oxford, England : 1990)|July 1, 2022
Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic reviewNicolò Matteo Luca Battisti, Nienke De Glas, Enrique Soto-Perez-de-Celis, et al.BJU International|June 26, 2013
Bone metastases in germ cell tumours: lessons learnt from a large retrospective studyMariam Jamal-Hanjani, Anna Karpathakis, Amy Kwan, et al.Journal of Opioid Management|September 25, 2024
Overcoming challenges of prescribing long-term opioid therapy in residency clinicsKathryn Brown, Joel Farley, Ezra Golberstein, et al.Journal of Geriatric Oncology|October 31, 2020
Age specific recruitment and retention to a large multicentre observational breast cancer trial in older women: The Age Gap TrialAnnaliza Todd, Charlene Martin, Jenna Morgan, et al.Journal of Geriatric Oncology|March 26, 2025
Preferences for quality of life versus length of life in older women deciding about treatment for early breast cancer: A cross-sectional sub-analysis of the Bridging the Age Gap studyJenna L Morgan, Anne Shrestha, Charlene Martin, et al.Cancer|April 4, 2003
Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick)David Khayat, Olivier Rixe, Ginette Martin, et al.Breast Cancer Research and Treatment|August 20, 2021
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded populationMichelino De Laurentiis, Simona Borstnar, Mario Campone, et al.Pageof 12